Meyer HA - Search Results

1

Reduced serum selenoprotein P concentrations in German prostate cancer patients.

Meyer HA, Hollenbach B, Stephan C, Endermann T, Morgenthaler NG, Cammann H, Köhrle J, Jung K, Schomburg L. Meyer HA, et al. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2386-90. doi: 10.1158/1055-9965.EPI-09-0262. Epub 2009 Aug 18. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19690186

2

A (-5, -7) proPSA based artificial neural network to detect prostate cancer.

Stephan C, Meyer HA, Kwiatkowski M, Recker F, Cammann H, Loening SA, Jung K, Lein M. Stephan C, et al. Among authors: meyer ha. Eur Urol. 2006 Nov;50(5):1014-20. doi: 10.1016/j.eururo.2006.04.011. Epub 2006 May 2. Eur Urol. 2006. PMID: 16697520

3

Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network.

Stephan C, Meyer HA, Cammann H, Nakamura T, Diamandis EP, Jung K. Stephan C, et al. Among authors: meyer ha. Biol Chem. 2006 Jun;387(6):801-5. doi: 10.1515/BC.2006.101. Biol Chem. 2006. PMID: 16800743

4

Serum (-5, -7) proPSA for distinguishing stage and grade of prostate cancer.

Stephan C, Meyer HA, Paul EM, Kristiansen G, Loening SA, Lein M, Jung K. Stephan C, et al. Among authors: meyer ha. Anticancer Res. 2007 Jul-Aug;27(4A):1833-6. Anticancer Res. 2007. PMID: 17649780 Free article. Clinical Trial.

5

Comparison of two different artificial neural networks for prostate biopsy indication in two different patient populations.

Stephan C, Xu C, Finne P, Cammann H, Meyer HA, Lein M, Jung K, Stenman UH. Stephan C, et al. Among authors: meyer ha. Urology. 2007 Sep;70(3):596-601. doi: 10.1016/j.urology.2007.04.004. Epub 2007 Aug 3. Urology. 2007. PMID: 17688922

6

An artificial neural network for five different assay systems of prostate-specific antigen in prostate cancer diagnostics.

Stephan C, Cammann H, Meyer HA, Müller C, Deger S, Lein M, Jung K. Stephan C, et al. Among authors: meyer ha. BJU Int. 2008 Sep;102(7):799-805. doi: 10.1111/j.1464-410X.2008.07765.x. Epub 2008 Jun 3. BJU Int. 2008. PMID: 18522632

7

Artificial neural network (ANN) velocity better identifies benign prostatic hyperplasia but not prostate cancer compared with PSA velocity.

Stephan C, Büker N, Cammann H, Meyer HA, Lein M, Jung K. Stephan C, et al. Among authors: meyer ha. BMC Urol. 2008 Sep 2;8:10. doi: 10.1186/1471-2490-8-10. BMC Urol. 2008. PMID: 18764937 Free PMC article.

8

Between-method differences in prostate-specific antigen assays affect prostate cancer risk prediction by nomograms.

Stephan C, Siemssen K, Cammann H, Friedersdorff F, Deger S, Schrader M, Miller K, Lein M, Jung K, Meyer HA. Stephan C, et al. Among authors: meyer ha. Clin Chem. 2011 Jul;57(7):995-1004. doi: 10.1373/clinchem.2010.151472. Epub 2011 May 24. Clin Chem. 2011. PMID: 21610217

9

Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men.

Stephan C, Xu C, Cammann H, Graefen M, Haese A, Huland H, Semjonow A, Diamandis EP, Remzi M, Djavan B, Wildhagen MF, Blijenberg BG, Finne P, Stenman UH, Jung K, Meyer HA. Stephan C, et al. Among authors: meyer ha. World J Urol. 2007 Mar;25(1):95-103. doi: 10.1007/s00345-006-0132-9. Epub 2007 Feb 28. World J Urol. 2007. PMID: 17333205

10

Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies.

Stephan C, Kramer J, Meyer HA, Kristiansen G, Ziemer S, Deger S, Lein M, Loening SA, Jung K. Stephan C, et al. Among authors: meyer ha. BJU Int. 2007 Jun;99(6):1427-31. doi: 10.1111/j.1464-410X.2007.06805.x. Epub 2007 Mar 12. BJU Int. 2007. PMID: 17355366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page